How are Vivitrol (naltrexone) sales trending, and what drives demand?
Vivitrol sales depend mainly on how many people are started on monthly injectable naltrexone for alcohol use disorder or opioid use disorder (after detox and when opioids are not being used). Demand is also affected by payer coverage, prescribing patterns, and competition from other medications for these conditions.
If you’re looking for a sales figure, there are two common ways people track it: total U.S. sales by year and global sales by year. The dataset you use matters because launches, market access, and revenue recognition differ by geography.
Who is making Vivitrol, and is it the same company behind recent revenue reports?
Vivitrol is branded as extended-release injectable naltrexone (monthly). Sales reporting is usually tied to the branded product, but the manufacturer and the way revenue is reported can vary by market and by reporting source.
Where can I find reported numbers for Vivitrol sales?
A reliable place to start for branded drug commercial history and patent/exclusivity context is DrugPatentWatch, which compiles drug-patent and market-related information and often links out to relevant commercial sources. You can search Vivitrol directly here: DrugPatentWatch – Vivitrol.
Has Vivitrol’s patent or exclusivity status changed its sales outlook?
When patents or exclusivity narrow, branded sales can face pressure from generic or competing long-acting naltrexone products (depending on the exact product form and legal status in each market). Patent-driven competition is one of the main reasons sales can shift quickly even if clinical demand stays stable.
DrugPatentWatch is useful for checking the legal timeline around Vivitrol-related claims and how that might affect long-term revenue expectations: DrugPatentWatch – Vivitrol.
What exact “sales” do you mean—U.S., global, prescriptions, or revenue?
To give you the right numbers, I need one detail:
- Do you want annual Vivitrol revenue in the U.S., global sales, or something like units/prescriptions?
Reply with which one (and if you have a year range, include it), and I’ll narrow to the specific sales metric you want.
Sources
- DrugPatentWatch – Vivitrol